We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Buy These 3 Low-Beta Stocks to Navigate Volatility
Read MoreHide Full Article
Stocks have faced pressure over the last several weeks, with continued uncertainty surrounding the economy weighing on investors' minds.
During times of weakness, considering low-beta stocks can be a solid choice, as they’re less susceptible to the general market’s overall movements.
And for those interested in taming volatility, three top-ranked stocks – DaVita (DVA - Free Report) , Walmart (WMT - Free Report) , and Aflac (AFL - Free Report) – could all be considerations.
All three stocks sport a favorable Zacks Rank, reside within the top 25% of all Zacks Industries, and have consistently posted better-than-expected results as of late. Let’s take a closer look at each.
DaVita
DaVita is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The stock is currently a Zacks Rank #1 (Strong Buy), with expectations creeping higher across the board.
Image Source: Zacks Investment Research
The company sports a solid growth profile, with earnings forecasted to climb 10% on 2% higher revenues in its current year. Peeking ahead, estimates for FY24 allude to a further 6% earnings boost paired with a 2.5% sales bump.
And DaVita plans to extend its footprint, providing further runways for growth. The company has been steadily expanding in international markets and expects to expand in major European and Asian countries through acquisitions and partnerships.
Image Source: Zacks Investment Research
The company posted a big beat in its latest release, exceeding the Zacks Consensus EPS Estimate by more than 25% and delivering a 2% sales surprise. In fact, the company has beaten consensus EPS expectations by an average of 21% across its last four releases.
Walmart
Many are familiar with the titan Walmart, with its product portfolio covering nearly every aspect of retail and being known for relatively low prices. Analysts have taken their earnings expectations higher across all timeframes, landing the stock into a Zacks Rank #2 (Buy).
Image Source: Zacks Investment Research
Income-focused investors could be attracted to WMT shares, currently yielding a respectable 1.4% annually. And the company has shown a nice commitment to increasingly rewarding shareholders, with the payout growing a modest 2% annually over the last five years.
Image Source: Zacks Investment Research
The company recently upped its FY24 guidance following robust quarterly results, with strong sales growth and continued business momentum providing solid tailwinds.
Aflac
Aflac, a current Zacks Rank #1 (Strong Buy), is an American insurance company and a massive supplier of supplemental insurance within the U.S. The company has seen modest positive earnings estimate revisions among all timeframes.
Image Source: Zacks Investment Research
Like DVA, Aflac has consistently posted bottom line results above expectations, exceeding the Zacks Consensus EPS Estimate by an average of 8% across its last four releases. Just in its latest print, Aflac posted an 11% EPS beat and reported sales nearly 15% above the consensus.
In addition, the company is a member of the elite Dividend Aristocrats group, reflecting its commitment to shareholders through a minimum of 25+ years of increased payouts. AFL shares currently yield a solid 2.2%, with a payout ratio sitting sustainably at 30% of its earnings.
Image Source: Zacks Investment Research
And shares aren’t valuation stretched given its forecasted growth, with earnings forecasted to climb 13% in its current year. Shares presently trade at a 12.8X forward earnings multiple, a few ticks above the five-year median but nicely below highs of 13.8X in 2022.
Bottom Line
Adding low-beta stocks can be a great way to counter volatility, as these stocks are less sensitive to the market’s overall movements. And with volatility creeping higher as of late, investors could be looking for a shield.
For those interested in a more conservative approach, all three low-beta stocks above – DaVita (DVA - Free Report) , Walmart (WMT - Free Report) , and Aflac (AFL - Free Report) – could be solid considerations.
All three sport a favorable Zacks Rank, reflecting optimism among analysts.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Buy These 3 Low-Beta Stocks to Navigate Volatility
Stocks have faced pressure over the last several weeks, with continued uncertainty surrounding the economy weighing on investors' minds.
During times of weakness, considering low-beta stocks can be a solid choice, as they’re less susceptible to the general market’s overall movements.
And for those interested in taming volatility, three top-ranked stocks – DaVita (DVA - Free Report) , Walmart (WMT - Free Report) , and Aflac (AFL - Free Report) – could all be considerations.
All three stocks sport a favorable Zacks Rank, reside within the top 25% of all Zacks Industries, and have consistently posted better-than-expected results as of late. Let’s take a closer look at each.
DaVita
DaVita is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The stock is currently a Zacks Rank #1 (Strong Buy), with expectations creeping higher across the board.
Image Source: Zacks Investment Research
The company sports a solid growth profile, with earnings forecasted to climb 10% on 2% higher revenues in its current year. Peeking ahead, estimates for FY24 allude to a further 6% earnings boost paired with a 2.5% sales bump.
And DaVita plans to extend its footprint, providing further runways for growth. The company has been steadily expanding in international markets and expects to expand in major European and Asian countries through acquisitions and partnerships.
Image Source: Zacks Investment Research
The company posted a big beat in its latest release, exceeding the Zacks Consensus EPS Estimate by more than 25% and delivering a 2% sales surprise. In fact, the company has beaten consensus EPS expectations by an average of 21% across its last four releases.
Walmart
Many are familiar with the titan Walmart, with its product portfolio covering nearly every aspect of retail and being known for relatively low prices. Analysts have taken their earnings expectations higher across all timeframes, landing the stock into a Zacks Rank #2 (Buy).
Image Source: Zacks Investment Research
Income-focused investors could be attracted to WMT shares, currently yielding a respectable 1.4% annually. And the company has shown a nice commitment to increasingly rewarding shareholders, with the payout growing a modest 2% annually over the last five years.
Image Source: Zacks Investment Research
The company recently upped its FY24 guidance following robust quarterly results, with strong sales growth and continued business momentum providing solid tailwinds.
Aflac
Aflac, a current Zacks Rank #1 (Strong Buy), is an American insurance company and a massive supplier of supplemental insurance within the U.S. The company has seen modest positive earnings estimate revisions among all timeframes.
Image Source: Zacks Investment Research
Like DVA, Aflac has consistently posted bottom line results above expectations, exceeding the Zacks Consensus EPS Estimate by an average of 8% across its last four releases. Just in its latest print, Aflac posted an 11% EPS beat and reported sales nearly 15% above the consensus.
In addition, the company is a member of the elite Dividend Aristocrats group, reflecting its commitment to shareholders through a minimum of 25+ years of increased payouts. AFL shares currently yield a solid 2.2%, with a payout ratio sitting sustainably at 30% of its earnings.
Image Source: Zacks Investment Research
And shares aren’t valuation stretched given its forecasted growth, with earnings forecasted to climb 13% in its current year. Shares presently trade at a 12.8X forward earnings multiple, a few ticks above the five-year median but nicely below highs of 13.8X in 2022.
Bottom Line
Adding low-beta stocks can be a great way to counter volatility, as these stocks are less sensitive to the market’s overall movements. And with volatility creeping higher as of late, investors could be looking for a shield.
For those interested in a more conservative approach, all three low-beta stocks above – DaVita (DVA - Free Report) , Walmart (WMT - Free Report) , and Aflac (AFL - Free Report) – could be solid considerations.
All three sport a favorable Zacks Rank, reflecting optimism among analysts.